Metabolic Acidosis Alters Expression of Slc22 Transporters in Mouse Kidney.


Journal

Kidney & blood pressure research
ISSN: 1423-0143
Titre abrégé: Kidney Blood Press Res
Pays: Switzerland
ID NLM: 9610505

Informations de publication

Date de publication:
2020
Historique:
received: 16 11 2019
accepted: 20 01 2020
pubmed: 18 2 2020
medline: 5 11 2020
entrez: 17 2 2020
Statut: ppublish

Résumé

The kidneys play a central role in eliminating metabolic waste products and drugs through transporter-mediated excretion along the proximal tubule. This task is mostly achieved through a variety of transporters from the solute carrier family 22 (SLC22) family of organic cation and anion transporters. Metabolic acidosis modulates metabolic and renal functions and also affects the clearance of metabolites and drugs from the body. We had previously shown that induction of metabolic acidosis in mice alters a large set of transcripts, among them also many transporters including transporters from the Slc22 family. Here we further investigated the impact of acidosis on Slc22 family members. Metabolic acidosis was induced for 2 or 7 days with NH4Cl, some animals also received the uricase inhibitor oxonic acid for comparison. Expression of transporters was studied by qPCR and immunoblotting. NH4Cl induced no significant changes in plasma or urine uric acid levels but caused downregulation of Slc22a1 (Oct1), Slc22a6 (Oat1), Slc22a19 (Oat5), and -Slc22a12 (Urat1) at mRNA level. In contrast, Slc22a4 mRNA (Octn1) was upregulated. On protein level, NH4Cl increased Octn1 (after 7 days) and Urat1 (after 2 days) abundance and decreased Oat1 (after 2 days) and Urat1 (after 7 days). Oxonic acid had no impact on protein abundance of any of the transporters tested. In summary, metabolic acidosis alters expression of several transporters involved in renal excretion of metabolic waste products and drugs. This may have implications for drug kinetics and clearance of waste metabolites.

Identifiants

pubmed: 32062662
pii: 000506052
doi: 10.1159/000506052
doi:

Substances chimiques

Catecholamine Plasma Membrane Transport Proteins 0
Octamer Transcription Factor-1 0
Organic Anion Transporters 0
Pou2f1 protein, mouse 0
RNA, Messenger 0
Slc22a1 protein, mouse 0
Slc22a12 protein, mouse 0
Uric Acid 268B43MJ25

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-274

Informations de copyright

© 2020 The Author(s) Published by S. Karger AG, Basel.

Auteurs

Janine Gottier Nwafor (J)

Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Marta Nowik (M)

Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.

Naohiko Anzai (N)

Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba, Japan.

Hitoshi Endou (H)

Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo, Japan.

Carsten A Wagner (CA)

Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland, carsten.wagner@physiol.uzh.ch.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH